Q1 2025 Cellebrite DI Ltd Earnings Call

Participants

Andrew Kramer; Vice President, Investor Relations; Cellebrite DI Ltd

Thomas Hogan; Interim Chief Executive Officer; Cellebrite DI Ltd

Dana Gerner; Chief Financial Officer; Cellebrite DI Ltd

Marcus Jewell; Global Chief Revenue Officer; Cellebrite DI Ltd

Tomer Zilberman; Analyst; Bank of America

Jeff Van Rhee; Analyst; Craig-Hallum Capital Group

Mike Cikos; Analyst; Needham

Jonathan Ho; Analyst; William Blair

Shaul Eyal; Analyst; TD Cowen

Eric Martinuzzi; Analyst; Lake Street Capital Markets

Presentation

Operator

Welcome to the Cellebrite first quarter 2025 financial results conference call. At this time, all participants have been placed on a listen-only mode, and the floor will be open for questions following the presentation. (Operator Instructions)
I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.

Andrew Kramer

Thank you very much, Erica. Welcome everybody to Cellebrite's first quarter 2025 financial results call. I'm joined here today at our US headquarters outside of Washington, DC by our primary speakers: Tom Hogan, Cellebrite's Interim CEO, and Dana Gerner, Cellebrite's CFO. Joining us in person is Marcus Jewell, our CRO, and Ronnen Armon, our Chief Products and Technology Officer, is participating remotely. Marcus and Ronan will be available during Q&A.
There's a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary. We'll call out the slide number we're referring to in our remarks. This call is being recorded, and a replay of the recording will be made available on our website shortly after the call, along with a copy of the prepared remarks.
And starting on slide number 2, a copy of today's press release and financial statements, including GAAP to non-GAAP reconciliations, the slide presentation, and the quarterly financial tables and supplemental historical financial information for each quarter of the past couple of years are available on the Investor Relations website and investors.cellebrite.com.
Also, unless stated otherwise, our discussion of our first quarter 2025 financial metrics, as well as the financial metrics provided in our outlook will be done on a non-GAAP basis only, and all historical comparisons are with the first quarter of 2024. In addition, please note that statements made during this call that are not statements of historical facts, constitute forward-looking statements.
All forward-looking statements are subject to risk and uncertainties and other factors that could cause matters expressed or implied by those forward-looking statements not to occur. They could also cause actual results to differ materially from historical results and/or from forecasts.
Some of these forward-looking statements are discussed under the heading Risk Factors and elsewhere in the company's Annual Report on Form 20-F filed with the SEC on March 18, 2025. The company does not undertake to update any forward-looking statements to reflect future events or circumstances. Slide number 3 provides the agenda of the topics we'll cover on today's call.
And with that being said, I'll now turn the call over to Tom Hogan. Tom?